Injectable agents and hearing loss in the treatment of patients with rifampicin-resistant tuberculosis: a nationwide multicenter prospective study

Journal of Microbiology, Immunology and Infection · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles